Nantahala Capital Management, LLC Htg Molecular Diagnostics, Inc Transaction History

Nantahala Capital Management, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$0.46 - $1.45 $131,542 - $414,646	-285,963 Closed	0 $0
Q1 2022 May 13, 2022	SELL	$1.39 - $5.51 $68,182 - $270,276	-49,052 Reduced 14.64%	285,963 $397,000
Q4 2021 Feb 14, 2022	SELL	$3.23 - $5.97 $39,263 - $72,571	-12,156 Reduced 3.5%	335,015 $1.82 Million
Q3 2021 Nov 15, 2021	SELL	$5.01 - $6.8 $82,419 - $111,866	-16,451 Reduced 4.52%	347,171 $1.98 Million
Q4 2020 Feb 16, 2021	BUY	$4.14 - $5.95 $1.51 Million - $2.16 Million	363,622 New	363,622 $1.74 Million

Ticker HTGM
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 11,048,100
Market Cap $3.76M
Description
HTG Molecular Diagnostics, Inc. a life sciences company, focuses on the precision medicine. The company offers instruments; consumables comprising assay kits; and software that automate sample processing and profiles various molecular targets. Its marketed molecular profiling panels include HTG Transcriptome Panel; HTG EdgeSeq precision immuno-o...

Get notified when there are updates to the investment portfolio of Nantahala Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Nantahala Capital Management, LLC with notifications on news.